These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28718965)

  • 1. Long-term effects: Galectin-1 and specific immunotherapy for allergic responses in the intestine.
    Yang LT; Shu Q; Luo XQ; Liu ZQ; Qiu SQ; Liu JQ; Guo HJ; Li LJ; Li MG; Liu DB; Xia LX; Liu ZG; Yang PC
    Allergy; 2018 Jan; 73(1):106-114. PubMed ID: 28718965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of Galectin-9 on allergen-specific sublingual immunotherapy in a Dermatophagoides farinae-induced mouse model of chronic asthma.
    Ikeda M; Katoh S; Shimizu H; Hasegawa A; Ohashi-Doi K; Oka M
    Allergol Int; 2017 Jul; 66(3):432-439. PubMed ID: 27876361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunological mechanisms contributing to the clinical efficacy of allergen specific immunotherapy (SIT) in allergic diseases].
    Asher I; Mahlab-Guri K; Sthoeger Z
    Harefuah; 2013 Sep; 152(9):529-33, 564, 563. PubMed ID: 24364093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.
    Chen X; Song CH; Liu ZQ; Feng BS; Zheng PY; Li P; In SH; Tang SG; Yang PC
    Allergy; 2011 Aug; 66(8):1038-46. PubMed ID: 21426359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sublingual immunotherapy on allergic inflammation.
    Incorvaia C; Frati F; Puccinelli P; Marcucci F; Di Cara G; Sensi L; Scurati S; Yacoub MR; Moingeon P
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):167-72. PubMed ID: 18782023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunotherapy and turning off the T cell: how does it work?
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):381-92. PubMed ID: 22018608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
    Nieminen K; Laaksonen K; Savolainen J
    Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model.
    Castillo-Courtade L; Han S; Lee S; Mian FM; Buck R; Forsythe P
    Allergy; 2015 Sep; 70(9):1091-102. PubMed ID: 25966668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory cells in allergen-specific immunotherapy.
    Soyka MB; Holzmann D; Akdis CA
    Immunotherapy; 2012 Apr; 4(4):389-96. PubMed ID: 22512633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.
    Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA
    Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.
    Palomares O; Akdis M; Martín-Fontecha M; Akdis CA
    Immunol Rev; 2017 Jul; 278(1):219-236. PubMed ID: 28658547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell regulatory mechanisms in specific immunotherapy.
    Jutel M; Akdis C
    Chem Immunol Allergy; 2008; 94():158-177. PubMed ID: 18802346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
    Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
    Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of regulatory T cells by intranasal allergen immunotherapy in an experimental rat model of airway allergy.
    Moitra S; Datta A; Mondal S; Hazra I; Faruk SMO; Das PK; Basu AK; Tripathi SK; Chaudhuri S
    Int Immunopharmacol; 2017 Jun; 47():9-19. PubMed ID: 28349869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
    Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV
    Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rush desensitization with a single antigen induces subclinical activation of mast cells and protects against bystander challenge in dually sensitized mice.
    Killoran KE; Kropp LE; Lindrose AR; Curtis HE; Cook D; Mitre E
    Clin Exp Allergy; 2019 Apr; 49(4):484-494. PubMed ID: 30506823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.